Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.57
-0.13-7.65%
At close: -
$1.60
0.031.90%
After Hours: Jun 27, 7:45 PM EDT
Comments
Loading...
Cabaletta Bio Analyst Ratings and Price Targets | NASDAQ:CABA | Benzinga
Cabaletta Bio Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Cabaletta Bio Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Citigroup
Guggenheim
Wells Fargo
UBS
1calculated from analyst ratings
Analyst Ratings for Cabaletta Bio
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/11/2025 | Buy Now | — | HC Wainwright & Co. | Douglas Tsao52% | $25 → $25 | Reiterates | Buy → Buy | Get Alert |
| 05/16/2025 | Buy Now | — | Citigroup | Samantha Semenkow33% | $17 → $13 | Maintains | Buy | Get Alert |
| 05/16/2025 | Buy Now | — | Guggenheim | Yatin Suneja55% | $23 → $25 | Maintains | Buy | Get Alert |
| 05/15/2025 | Buy Now | — | Guggenheim | Yatin Suneja55% | $23 → $25 | Maintains | Buy | Get Alert |
| 04/01/2025 | Buy Now | — | Wells Fargo | Derek Archila62% | $6 → $3 | Maintains | Equal-Weight | Get Alert |
| 04/01/2025 | Buy Now | — | Guggenheim | Yatin Suneja55% | $23 → $23 | Reiterates | Buy → Buy | Get Alert |
| 04/01/2025 | Buy Now | — | UBS | Trung Huynh71% | $10 → $7 | Maintains | Buy | Get Alert |
| 04/01/2025 | Buy Now | — | Morgan Stanley | Michael Ulz66% | $30 → $22 | Maintains | Overweight | Get Alert |
| 04/01/2025 | Buy Now | — | HC Wainwright & Co. | Douglas Tsao52% | $25 → $25 | Reiterates | Buy → Buy | Get Alert |
| 02/18/2025 | Buy Now | — | HC Wainwright & Co. | Douglas Tsao52% | $25 → $25 | Reiterates | Buy → Buy | Get Alert |
| 01/17/2025 | Buy Now | — | HC Wainwright & Co. | Douglas Tsao52% | $25 → $25 | Reiterates | Buy → Buy | Get Alert |
| 12/20/2024 | Buy Now | — | Evercore ISI Group | Gavin Clark-Gartner38% | $15 → $6 | Downgrade | Outperform → In-Line | Get Alert |
| 12/19/2024 | Buy Now | — | Wells Fargo | Derek Archila62% | $12 → $6 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 11/18/2024 | Buy Now | — | HC Wainwright & Co. | Douglas Tsao52% | $25 → $25 | Reiterates | Buy → Buy | Get Alert |
| 11/15/2024 | Buy Now | — | Wells Fargo | Derek Archila62% | $20 → $12 | Maintains | Overweight | Get Alert |
| 11/15/2024 | Buy Now | — | HC Wainwright & Co. | Douglas Tsao52% | $25 → $25 | Reiterates | Buy → Buy | Get Alert |
| 10/10/2024 | Buy Now | — | UBS | Trung Huynh71% | → $10 | Initiates | → Buy | Get Alert |
| 09/17/2024 | Buy Now | — | HC Wainwright & Co. | Douglas Tsao52% | $25 → $25 | Reiterates | Buy → Buy | Get Alert |
| 08/12/2024 | Buy Now | — | Wells Fargo | Derek Archila62% | $35 → $20 | Maintains | Overweight | Get Alert |
| 08/12/2024 | Buy Now | — | Evercore ISI Group | Gavin Clark-Gartner38% | $25 → $15 | Maintains | Outperform | Get Alert |
| 08/09/2024 | Buy Now | — | HC Wainwright & Co. | Douglas Tsao52% | $30 → $25 | Maintains | Buy | Get Alert |
| 06/21/2024 | Buy Now | — | Cantor Fitzgerald | Josh Schimmer57% | $50 → $50 | Reiterates | Overweight → Overweight | Get Alert |
| 06/17/2024 | Buy Now | — | Stifel | Ben Burnett9% | $32 → $32 | Maintains | Buy | Get Alert |
| 06/14/2024 | Buy Now | — | HC Wainwright & Co. | Douglas Tsao52% | $30 → $30 | Reiterates | Buy → Buy | Get Alert |
| 05/24/2024 | Buy Now | — | HC Wainwright & Co. | Douglas Tsao52% | $30 → $30 | Reiterates | Buy → Buy | Get Alert |
| 05/16/2024 | Buy Now | — | HC Wainwright & Co. | Douglas Tsao52% | $30 → $30 | Reiterates | Buy → Buy | Get Alert |
| 04/05/2024 | Buy Now | — | Cantor Fitzgerald | Joshua Schimmer45% | $50 → $50 | Reiterates | Overweight → Overweight | Get Alert |
| 04/04/2024 | Buy Now | — | Citigroup | Samantha Semenkow33% | $26 → $30 | Maintains | Buy | Get Alert |
| 03/22/2024 | Buy Now | — | Cantor Fitzgerald | Joshua Schimmer45% | $50 → $50 | Reiterates | Overweight → Overweight | Get Alert |
| 03/22/2024 | Buy Now | — | Wells Fargo | Derek Archila62% | $34 → $35 | Maintains | Overweight | Get Alert |
| 03/22/2024 | Buy Now | — | HC Wainwright & Co. | Douglas Tsao52% | $25 → $30 | Maintains | Buy | Get Alert |
| 03/21/2024 | Buy Now | — | Stifel | Ben Burnett9% | $31 → $32 | Maintains | Buy | Get Alert |
| 02/05/2024 | Buy Now | — | Jefferies | Kelly Shi43% | → $36 | Initiates | → Buy | Get Alert |
| 11/29/2023 | Buy Now | — | Morgan Stanley | Michael Ulz66% | $28 → $25 | Maintains | Overweight | Get Alert |
| 11/29/2023 | Buy Now | — | HC Wainwright & Co. | Douglas Tsao52% | → $25 | Reiterates | Buy → Buy | Get Alert |
| 11/15/2023 | Buy Now | — | Cantor Fitzgerald | Joshua Schimmer45% | $40 → $50 | Maintains | Overweight | Get Alert |
| 11/10/2023 | Buy Now | — | Wells Fargo | Derek Archila62% | $39 → $34 | Maintains | Overweight | Get Alert |
| 11/10/2023 | Buy Now | — | HC Wainwright & Co. | Douglas Tsao52% | $17 → $25 | Maintains | Buy | Get Alert |
| 11/08/2023 | Buy Now | — | Morgan Stanley | Michael Ulz66% | $16 → $28 | Maintains | Overweight | Get Alert |
| 10/24/2023 | Buy Now | — | Cantor Fitzgerald | Joshua Schimmer45% | → $40 | Initiates | → Overweight | Get Alert |
| 10/19/2023 | Buy Now | — | Stifel | Ben Burnett9% | → $31 | Initiates | → Buy | Get Alert |
| 10/04/2023 | Buy Now | — | HC Wainwright & Co. | Douglas Tsao52% | → $17 | Reiterates | Buy → Buy | Get Alert |
| 09/18/2023 | Buy Now | — | Wells Fargo | Derek Archila62% | $14 → $39 | Maintains | Overweight | Get Alert |
| 09/05/2023 | Buy Now | — | Citigroup | Samantha Semenkow33% | → $22 | Initiates | → Buy | Get Alert |
| 08/14/2023 | Buy Now | — | Guggenheim | Yatin Suneja55% | → $34 | Reiterates | Buy → Buy | Get Alert |
| 08/11/2023 | Buy Now | — | HC Wainwright & Co. | Douglas Tsao52% | $15 → $17 | Maintains | Buy | Get Alert |
| 07/18/2023 | Buy Now | — | Guggenheim | Yatin Suneja55% | → $34 | Initiates | → Buy | Get Alert |
| 05/17/2023 | Buy Now | — | HC Wainwright & Co. | Douglas Tsao52% | → $15 | Reiterates | Buy → Buy | Get Alert |
| 05/12/2023 | Buy Now | — | HC Wainwright & Co. | Douglas Tsao52% | → $15 | Reiterates | Buy → Buy | Get Alert |
| 05/03/2023 | Buy Now | — | HC Wainwright & Co. | Douglas Tsao52% | → $15 | Reiterates | → Buy | Get Alert |
| 04/10/2023 | Buy Now | — | HC Wainwright & Co. | Douglas Tsao52% | → $15 | Reiterates | → Buy | Get Alert |
| 04/03/2023 | Buy Now | — | HC Wainwright & Co. | Douglas Tsao52% | → $15 | Reiterates | → Buy | Get Alert |
| 03/22/2023 | Buy Now | — | Chardan Capital | Geulah Livshits51% | → $12 | Reiterates | → Buy | Get Alert |
| 03/17/2023 | Buy Now | — | Mizuho | Uy Ear59% | → $10 | Reiterates | → Buy | Get Alert |
| 03/17/2023 | Buy Now | — | HC Wainwright & Co. | Douglas Tsao52% | $11 → $15 | Maintains | Buy | Get Alert |
| 02/17/2023 | Buy Now | — | HC Wainwright & Co. | Douglas Tsao52% | → $11 | Reiterates | → Buy | Get Alert |
| 01/27/2023 | Buy Now | — | Morgan Stanley | Michael Ulz66% | → $16 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 01/03/2023 | Buy Now | — | Wells Fargo | Derek Archila62% | $4 → $14 | Maintains | Overweight | Get Alert |
| 11/11/2022 | Buy Now | — | Chardan Capital | Geulah Livshits51% | $13 → $12 | Maintains | Buy | Get Alert |
| 09/14/2022 | Buy Now | — | Wells Fargo | Derek Archila62% | $14 → $4 | Maintains | Overweight | Get Alert |
| 08/30/2022 | Buy Now | — | Morgan Stanley | Michael Ulz66% | $15 → $3 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 08/12/2022 | Buy Now | — | Chardan Capital | Geulah Livshits51% | $17 → $13 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Cabaletta Bio (CABA) stock?
The latest price target for Cabaletta Bio (NASDAQ:CABA) was reported by HC Wainwright & Co. on June 11, 2025. The analyst firm set a price target for $25.00 expecting CABA to rise to within 12 months (a possible 1462.70% upside). 21 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Cabaletta Bio (CABA)?
The latest analyst rating for Cabaletta Bio (NASDAQ:CABA) was provided by HC Wainwright & Co., and Cabaletta Bio reiterated their buy rating.
When was the last upgrade for Cabaletta Bio (CABA)?
The last upgrade for Cabaletta Bio Inc happened on January 27, 2023 when Morgan Stanley raised their price target to $16. Morgan Stanley previously had an equal-weight for Cabaletta Bio Inc.
When was the last downgrade for Cabaletta Bio (CABA)?
The last downgrade for Cabaletta Bio Inc happened on December 20, 2024 when Evercore ISI Group changed their price target from $15 to $6 for Cabaletta Bio Inc.
When is the next analyst rating going to be posted or updated for Cabaletta Bio (CABA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cabaletta Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cabaletta Bio was filed on June 11, 2025 so you should expect the next rating to be made available sometime around June 11, 2026.
Is the Analyst Rating Cabaletta Bio (CABA) correct?
While ratings are subjective and will change, the latest Cabaletta Bio (CABA) rating was a reiterated with a price target of $25.00 to $25.00. The current price Cabaletta Bio (CABA) is trading at is $1.60, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
